Weil Company’s Progyny PGNY Stock Holding History

Weil Company’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,362	Closed	-$227K	–	151
2020 Q4	$227K	Sell	5,362 -2,300	-30%	-$74.8K	0.14%	122
2020 Q3	$225K	Buy	+7,662	New	+$211K	0.16%	96

Other funds holding PGNY

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Weil Company's PGNY Position: Q1 2021 in Review

Weil Company sold out of Progyny (PGNY) in Q1 2021, closing a stake of 5,362 shares — an estimated $227K sold.

Weil Company first reported a position in PGNY in Q3 2020 and held it in 2 quarters. The position peaked at $227K in Q4 2020. 210 funds tracked by Wall St. Rank hold PGNY as of Q1 2021.

Weil Company reported no remaining Progyny position as of Q1 2021 after selling out during the quarter.
Weil Company sold 5,362 Progyny shares in Q1 2021, an estimated $227K.
Weil Company first reported a position in Progyny in Q3 2020 and held it in 2 quarters.
Weil Company's Progyny position peaked at $227K in Q4 2020.
210 funds tracked by Wall St. Rank held Progyny as of Q1 2021.

Based on Weil Company's 13F filing for Q1 2021, filed 12 May 2021.